Last reviewed · How we verify
Chronic hormonal treatment
Chronic hormonal treatment is a Small molecule drug developed by Bayer. It is currently in Phase 2 development. Also known as: 1. Mirena (Levonorgestrel - IUS), 2. Qlaira (Estradiol valerate and dienogest), 3. Progevera (Medroxyprogesterone acetate), and any new hormonal treatment marketed in Spain that has the indication for HMB.
At a glance
| Generic name | Chronic hormonal treatment |
|---|---|
| Also known as | 1. Mirena (Levonorgestrel - IUS), 2. Qlaira (Estradiol valerate and dienogest), 3. Progevera (Medroxyprogesterone acetate), and any new hormonal treatment marketed in Spain that has the indication for HMB |
| Sponsor | Bayer |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Serum Betatrophin Levels in Normal-Weight and Overweight Adolescents With PCOS
- The Effect of Visceral Osteopathic Manual Therapy in Lumbar Disc Herniation (NA)
- The Influence of Combined Oral Contraception on the DEvelopment and progRession of Chronic venoUs diSeases (NA)
- Efficacy of Physical Therapy Treatment in Endometriosis and Its Relationship to Adherence Rates. (NA)
- Cabergoline for the Treatment of Chronic Pain Due to Endometriosis (PHASE2)
- Warfarin Effects on Male Fertility After Cardiac Surgery
- Electroacupuncture on Treating Cancer-related Depression (NA)
- ENDOGYM: A Holistic Approach With Pelvic Floor Physiotherapy and Yoga for Endometriosis Pain Relief
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Chronic hormonal treatment CI brief — competitive landscape report
- Chronic hormonal treatment updates RSS · CI watch RSS
- Bayer portfolio CI
Frequently asked questions about Chronic hormonal treatment
What is Chronic hormonal treatment?
Chronic hormonal treatment is a Small molecule drug developed by Bayer.
Who makes Chronic hormonal treatment?
Chronic hormonal treatment is developed by Bayer (see full Bayer pipeline at /company/bayer).
Is Chronic hormonal treatment also known as anything else?
Chronic hormonal treatment is also known as 1. Mirena (Levonorgestrel - IUS), 2. Qlaira (Estradiol valerate and dienogest), 3. Progevera (Medroxyprogesterone acetate), and any new hormonal treatment marketed in Spain that has the indication for HMB.
What development phase is Chronic hormonal treatment in?
Chronic hormonal treatment is in Phase 2.
Related
- Manufacturer: Bayer — full pipeline
- Also known as: 1. Mirena (Levonorgestrel - IUS), 2. Qlaira (Estradiol valerate and dienogest), 3. Progevera (Medroxyprogesterone acetate), and any new hormonal treatment marketed in Spain that has the indication for HMB
- Compare: Chronic hormonal treatment vs similar drugs
- Pricing: Chronic hormonal treatment cost, discount & access